We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Backs AstraZeneca, Impax Win In Zomig Patent Suit

Law360 (June 28, 2018, 4:14 PM EDT) -- The Federal Circuit on Thursday affirmed a Delaware federal court ruling that rejected arguments made by generic-drug maker Lannett Co. Inc. that two AstraZeneca AB nasal spray patents covering Impax's migraine...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

May 12, 2017

Law Firms

Companies

Government Agencies

Patents

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.